Because of the gaps in patient care and changes to health policy in such areas as vaccination, oncology, heart disease, HIV, hepatitis C (HCV) and other chronic conditions, there is a compelling need for the pharmaceutical industry to work more closely with patients, caregivers and patient organizations to better understand outcomes from the patient’s point of view, and to improve access to therapies, validate measurement tools and increase awareness of diseases.